Silverarc Capital Management »

Helix Acquisition Corp Ii Cl A shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Helix Acquisition Corp Ii Cl A (HLXB) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Helix Acquisition Corp Ii Cl A

Tip: Access up to 7 years of quarterly data

All positions including Helix Acquisition Corp Ii Cl A held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Helix Acquisition Corp Ii Cl A by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.1M 500k 10.22
2024-03-31 $5.2M 500k 10.40

More positions owned by Silverarc Capital Management

Merus N V (MRUS)
Nuvalent Inc-a (NUVL)
Avidity Biosciences Ord (RNA)
Urogen Pharma (URGN)
Erasca (ERAS)
Insmed Call Call Option
Morphic Hldg (MORF)
Akero Therapeutics (AKRO)
Celldex Therapeutics Com New (CLDX)
Intra Cellular Therapies (ITCI)
Poseida Therapeutics I (PSTX)
Cogent Biosciences (COGT)
Insmed Com Par $.01 (INSM)
Alnylam Pharmaceuticals (ALNY)
Elutia Cl A Com (ELUT)

View all positions for Silverarc Capital Management

Top funds holding Helix Acquisition Corp Ii Cl A

Cormorant Asset Management
BlackRock
Citadel Advisors
T. Rowe Price Associates
Millennium Management
OZ Management
Farallon Capital Management
Dr. Jeffrey R. Jay, M.D.
Perceptive Advisors
Silverarc Capital Management
Commodore Capital
Soros Fund Management
T. Rowe Price Investment Management
Ghost Tree Capital
Laurion Capital Management

View all funds holding Helix Acquisition Corp Ii Cl A